sur O3 Holding GmbH (isin : NO0013360552)
O3 Holding GmbH Releases Q4 2025 Interim Report
O3 Holding GmbH, the holding company for KD Pharma Group, has announced the publication of its Q4 2025 Interim Report. This release is part of the conditions for the company's FRN Senior Secured EUR 180,000,000 bond, under ISIN NO0013360552, originally issued on 28 October 2024. The report has been made publicly available on KD Pharma Group's website.
The publication of the Q4 2025 Interim Report marks a key regulatory requirement for O3 Holding GmbH. Investors can access detailed financial results and corporate developments via the company's online investor relations portal.
O3 Holding GmbH, located in Bexbach, Germany, continues to operate within the regulated unofficial market in Frankfurt. Stakeholders seeking further information can contact the company through the provided investor relations email.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de O3 Holding GmbH